Plexin: Difference between revisions
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 17: | Line 17: | ||
*Plexin A | *Plexin A | ||
**[[5l56]], [[5l59]], [[5l5c]] – mPLX-A1 extracellular domain segment 1-10 - mouse<br /> | |||
**[[5l7n]] – mPLX-A1 extracellular domain segment 7-10<br /> | |||
**[[3ryt]] - mPLX-A1 intracellular domain + Ras-related C3 botulinum toxin substrate<br /> | |||
**[[3al8]], [[3oky]] – mPLX-A2 + semaphorin-6A – mouse<br /> | **[[3al8]], [[3oky]] – mPLX-A2 + semaphorin-6A – mouse<br /> | ||
**[[4gza]] - mPLX-A2 + semaphorin-3A + neuropilin-1<br /> | **[[4gza]] - mPLX-A2 + semaphorin-3A + neuropilin-1<br /> | ||
**[[3al9]] | **[[3al9]] – mPLX-A2 SEMA+PSI domain<br /> | ||
**[[3okt]] - mPLX-A2 extracellular domain segment 1-4<br /> | |||
**[[5l5g]] – mPLX-A2 extracellular domain segment 1-8<br /> | |||
**[[5l74]] – mPLX-A2 extracellular domain segment 4-5<br /> | |||
**[[3q3j]] - hPLX-A2 binding domain + Rho-related GTP-binding protein Rho6 – human<br /> | |||
**[[3ig3]] - mPLX-A3 intracellular domain<br /> | **[[3ig3]] - mPLX-A3 intracellular domain<br /> | ||
**[[ | **[[5l5k]], [[5l5l]] – mPLX-A4 extracellular domain <br /> | ||
**[[ | **[[5l5k]] – mPLX-A4 extracellular domain segment 1-10<br /> | ||
**[[5l5l]] – mPLX-A4 extracellular domain segment 1-8<br /> | |||
**[[5l5m]], [[5l5n]] – mPLX-A4 extracellular domain segment 1-7<br /> | |||
**[[4e74]] - hPLX-A4 Rho GTPase-binding domain | **[[4e74]] - hPLX-A4 Rho GTPase-binding domain | ||
Line 31: | Line 40: | ||
**[[2rex]] - hPLX-B1 effector domain + Rho-related GTP-binding protein Rho6 | **[[2rex]] - hPLX-B1 effector domain + Rho-related GTP-binding protein Rho6 | ||
**[[2jph]] - hPLX-B1 | **[[2jph]] - hPLX-B1 effector domain – NMR<br /> | ||
**[[3ol2]] - hPLX-B1 + semaphorin 4D | **[[3ol2]] - hPLX-B1 + semaphorin 4D | ||
**[[3sua]], [[3su8]] – hPLX-B1 + RAS-related C3 botulinum toxin substrate | **[[3sua]], [[3su8]] – hPLX-B1 + RAS-related C3 botulinum toxin substrate | ||
**[[3hm6]] - hPLX-B1 cytoplasmic domain + peptide | **[[3hm6]] - hPLX-B1 cytoplasmic domain + peptide<br /> | ||
**[[5b4w]] - hPLX-B1 residues 20-535 + peptide inhibitor<br /> | |||
**[[4e71]] - hPLX-B2 effector domain<br /> | |||
**[[5e6p]] - hPLX-B2 cytoplasmic domain + Rho guanine nucleotide exchange factor 11<br /> | |||
*Plexin C | *Plexin C | ||
Line 47: | Line 58: | ||
*Plexin D | *Plexin D | ||
**[[3h6n]] - hPLX-D1 ubiquitin-like domain | **[[3h6n]] - hPLX-D1 ubiquitin-like domain<br /> | ||
**[[5v6r]] - mPLX-D1 intracellular domain <br /> | |||
**[[5v6t]] - mPLX-D1 intracellular domain + GIPC1<br /> | |||
}} | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |